See why investors love the new 12-month forecast for Novavax Inc(NVAX)

person holding a vaccine

Market Data

Novavax Inc(NVAX) is a stock of interest due to the large impact the company has on the market. Here at Wall Street Facts we only cover the best stocks so make sure you check out our other articles. Today we will be diving deep into all of the essential information you need to know about NVAX. We will be studying the movement so you can make the best decision as an investor. The stock has moved upwards today by 1%. The high for today is 213.98 and today’s low is 203.78. This information is critical in deciding whether this investment is risky or not. We can see the stock is trending upwards, which means the volume of people buying this stock is greater than people selling it.

Company Description

Novavax, Inc. focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It provides vaccines for COVID-19, seasonal flu, respiratory syncytial virus, Ebola, and Middle East respiratory syndrome. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Stock Forecast

As an investor, you can get an idea of where the stock is trending by the forecast. In this case, the high forecast for Novavax Inc is $480.00 and the low forecast is $377.00. Overall, Novavax Inc is in great shape going forward. They have a strong market cap of $15.39B and a very bright future ahead of them.

Leave a Reply

%d bloggers like this: